PAID-PL—The Polish Version of the Problem Areas in Diabetes Scale: Perfect Reliability and a One-Factor Structure by Cichoń, Ewelina et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
PAID-PL—The Polish Version of the Problem Areas in




Cichoń, Ewelina; Kiejna, Andrzej; Gondek, Tomasz M; Obrębski, Marcin; Sutkowska, Edyta; Lloyd, Cathy E.;
Sartorius, Norman and Kokoszka, Andrzej (2021). PAID-PL—The Polish Version of the Problem Areas in Diabetes
Scale: Perfect Reliability and a One-Factor Structure. Diabetes, Metabolic Syndrome and Obesity: Targets and
Therapy, 14 pp. 4433–4441.
For guidance on citations see FAQs.
c© [not recorded]
https://creativecommons.org/licenses/by-nc/4.0/
Version: Version of Record
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.2147/DMSO.S322850
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
O R I G I N A L  R E S E A R C H
PAID-PL—The Polish Version of the Problem 
Areas in Diabetes Scale: Perfect Reliability and 
a One-Factor Structure
Ewelina Cichoń1,2 
Andrzej Kiejna 1,2 
Tomasz M Gondek3,4 
Marcin Obrębski 5 
Edyta Sutkowska 6 
Cathy E Lloyd7 
Norman Sartorius8 
Andrzej Kokoszka 5
1Department of Psychology, WSB 
University in Torun, Torun, Wroclaw, 
Poland; 2Department of Psychology, 
Faculty of Applied Studies, University of 
Lower Silesia, Wroclaw, Poland; 
3Specialty Training Section, Polish 
Psychiatric Association, Wroclaw, Poland; 
4Section on Education, World Psychiatric 
Association, Wroclaw, Poland; 5II 
Department of Psychiatry, Medical 
University of Warsaw, Warsaw, Poland; 
6Department and Division of Medical 
Rehabilitation, Wroclaw Medical 
University, Wroclaw, Poland; 7Faculty of 
Health and Social Care, The Open 
University, Milton Keynes, UK; 
8Association for the Improvement of 
Mental Health Programmes (AIMH), 
Geneva, Switzerland 
Purpose: The aim of this study was to assess the structure and validate the Polish version of 
the Problem Areas in Diabetes (PAID) scale, as the current translations of the original 
English version significantly vary in their psychometric properties.
Patients and Methods: Two hundred and sixteen consecutive Polish outpatients were 
invited to participate in this international cross-sectional study on depression in diabetes. The 
research was based on the demographic and clinical characteristics of the study population, 
including the level of glycated hemoglobin (HbA1c) and scores obtained in the Polish 
versions of the following questionnaires: PAID, World Health Organization-Five Well- 
Being Index (WHO-5), Patient Health Questionnaire 9 (PHQ-9). The psychiatric diagnosis 
was conducted with the use of Mini-International Neuropsychiatric Interview (M.I.N.I.).
Results: Exploratory factor analyses yielded a 1-factor structure that included all 20 items. 
The internal consistency of the Polish version of PAID was high (Cronbach α = 0.97). There 
were significant positive correlation between PAID and PHQ-9 and a negative correlation 
between PAID and WHO-5. We also observed a negative association between PAID scores 
and age and a positive correlation between PAID and HbA1c levels. Patients with depression 
reported significantly higher PAID scores as compared with those without depressive 
symptoms.
Conclusion: The Polish version of PAID has a one-factor structure and is a reliable, valid 
outcome measure for Polish outpatients with type 2 diabetes and it may constitute a useful 
instrument for screening for psychologic issues in diabetic patients during their appointments 
at the diabetes clinic.
Keywords: diabetes mellitus, type 2, emotional stress, depression, quality of life, problem 
areas in diabetes scale
Introduction
In 2017, 451 million people suffered from diabetes, and it is expected that 
693 million individuals will be affected by diabetes in 2045.1,2 Diabetes frequently 
leads to serious, life-threatening, and often lethal cardiovascular complications, 
such as heart attack, stroke, neuropathy (nerve damage), nephropathy (kidney 
damage), and retinopathy (eye damage).3–5 The management of diabetes requires 
the daily monitoring of blood glucose levels and modification of the patient’s life 
style, which mainly means maintaining a healthy diet and doing regular physical 
exercise. Ultimately, adhering to these requirements poses a problem to many 
patients with diabetes.
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Psychological factors indeed play a role in this process. 
In the current guidelines for diabetes treatment, ie, those 
endorsed by the American Diabetes Association,3 Polish 
Diabetes Association,4 and International Diabetes 
Federation,5 it is recommended to include the psychologi-
cal aspects of diabetes in the diagnosis, treatment, and 
management of this disease.
The Problem Areas in Diabetes (PAID) scale is one of 
the most commonly used instruments to assess emotional 
distress related to problem areas that individuals with dia-
betes might have. It is a 20-item self-report measure that is 
applicable in both type 1 and type 2 diabetes.6 This tool is 
considered a recommended measure of diabetes-related 
emotional distress.6–8 It has been translated into 12 lan-
guages and validated in several countries.9–11 It also has 
short five- and one-item versions.12 The PAID-5 scale has 
high sensitivity (94%) and specificity (89%) for recognition 
of diabetes-related emotional distress. The one-item ver-
sion, ie, PAID-1, has both sensitivity and specificity of 
approximately 80% for recognition of diabetes-related 
emotional distress. The PAID-5 total score very strongly 
correlates with the PAID-20 total score: r = 0.92, p < 0.001. 
PAID was originally constructed in English, as a single- 
domain structure in which all items dealing with emotional 
distress are related to problems connected with diabetes.13 
Indeed, in a cross-cultural Dutch and United States study, 
principal component analyses confirmed the presence of 
a single, general 20-item factor; however, a four-factor 
solution was found in the exploratory factor analysis.6 The 
four factors were: negative emotions, treatment problems, 
food-related problems, and lack of social support.6 These 
dimensions have been widely applied in research that has 
been conducted in Dutch and in English, although the 
factorial structure of PAID seems culturally specific, eg, in 
a validation study of the Chinese version of PAID in 
Singapore, factor analysis resulted in a three-factor solution 
that included emotional and management problems, ability 
to cope with diabetes, and problems with social support.14 
However, this solution is not congruent with the one-factor 
structure of the Chinese version of PAID in Taiwan.15 Siaw 
et al suggested that some clinical (eg, distress intensity, 
duration of diabetes) and cultural differences among 
Taiwanese and Singaporean patients with diabetes as well 
as variations in health-care settings might explain the dif-
ferences in the factor structure of PAID.14 The three-factor 
solution was also found for the Swedish version of PAID, 
with the subdimensions being diabetes-related emotional 
problems, treatment-related problems, and social support– 
related problems.16 Similarly, in a Greek study that included 
two populations (ie, patients from an urban hospital and 
patients from a rural primary health-care center), factor 
analysis yielded three factors, ie, diabetes-related emotional 
problems, food-related problems, and social support– 
related problems.17 It is worth mentioning that although 
both the Greek and the Swedish versions of PAID have 
a three-factor structure, the Greek version includes food- 
related problems, whereas the Swedish version contains 
treatment-related problems instead. Conversely, the factor 
analysis of the Icelandic version of PAID revealed two 
factors related to distress in relation to life with diabetes 
and distress in relation to the management of diabetes.9 
A similar finding was shown for the Turkish version of 
PAID, which identified a diabetes distress factor and 
a social support–related factor.10
Conversely, some studies disregard any potential cul-
tural differences in the structure of PAID and follow the 
subdimensions identified by Snoek et al.6 For example, the 
factor analysis of the Brazilian PAID version yielded one 
component including all 20 items, but researchers decided 
to analyze the scale according to four subdimensions: 1) 
emotional problems, 2) treatment-related problems, 3) 
food-related problems, and 4) social support–related pro-
blems, despite the questionable reliability of three compo-
nents (Cronbach α was 0.91, 0.60, 0.74, and 0.72, 
respectively).18 Gross et al.18 substantiated their decision 
by referring to the original version of PAID by Welch et al.13 
Notably, the principal component analyses of the original 
version of PAID showed high item loadings (>0.30) for all 
20 items on the first principal component (52.4% of the 
variance). The second component accounted for only 5.7% 
of the variance, and the third one, for 4.9%. These results 
confirmed the presence of a large, universal, general factor 
representing emotional functioning in diabetes and sup-
ported the use of a total score.13
Given that the factorial structure of PAID seems cultu-
rally specific, it is crucial to validate the language versions 
of this tool. PAID is a very easy to use, quick, and valuable 
measure of the emotional burden of living with diabetes. 
However, interpreting Polish translation of PAID accord-
ing to a widely used four-factor structure can be nonap-
plicable to the Polish population. Inadequate use of the 
tool may lead toincomprehensible and wrong treatment 
decisions in clinical practice and generate artifacts in 
research. The Polish translation of PAID is based on the 
original American version by Polonsky et al.7 and was not 
fully validated. Back translation into English revealed no 
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substantial differences. The reliability of PAID scales, as 
indicated by Cronbach α, was: 0.92 for the total PAID 
score, 0.90 for negative emotions, 0.46 for treatment- 
related problems, 0.57 for food-related problems, and 
0.61 for lack of social support.19
Thus, the aim of this study was to conduct the factor 
analysis of the Polish version of PAID in order to compare 
its structure with that of other PAID translations and to 
verify the reliability of the measure and its subscales.
Materials and Methods
The data analyzed in this study were obtained from 
a Polish sample of consecutive participants of the 
International Prevalence and Treatment of Depression 
and Diabetes (INTERPRET-DD) collaborative study, 
which was conducted in 14 countries.20 A total of 216 
participants (100 women, 116 men) aged 28 to 65 years 
(M = 57.42, SD = 7.32) took part in the study; the duration 
of diabetes among study participants ranged from 1 to 37 
years (M = 9.47, SD = 7.10). Most participants used only 
oral hypoglycemic agents (n = 147; 68.1%). Twenty 
patients (9.3%) took only insulin, and 46 participants 
(21.3%) used both oral agents and insulin. Two partici-
pants (0.9%) did not use any antidiabetic medications. 
A single person missed information about medications 
taken (0.5%).
Procedure
The general procedure of the study is described in detail in 
Lloyd et al.20,21
The outpatient clinic attendees with type 2 diabetes 
were invited to participate in the study by their treating 
diabetologist. Eligible study participants were adults (aged 
18–65 years) with type 2 diabetes diagnosed at least 12 
months earlier who provided written informed consent. 
The exclusion criteria were: diagnosis of type 1 diabetes, 
communication or cognitive disorders, severe diseases (eg, 
cancer, stroke in the last 6 months), currently being an 
inpatient or having hospitalization scheduled (unless for 
the self-management of diabetes), being pregnant or hav-
ing given birth in the last 6 months, and having a clinical 
diagnosis of dependency on alcohol or other substance 
(not tobacco) or schizophrenia.
Each eligible individual was asked about age, duration 
of diabetes, family history of diabetes, and presence or 
history of diabetes complications (cardiovascular disease, 
retinopathy, peripheral neuropathy, peripheral vascular dis-
ease, kidney disease and comorbidities), the most recent 
blood pressure measurement, HbA1c level, as well as 
height and weight, location of their accommodation 
(rural or urban area), level of education (no formal, some 
or completed primary school, some or completed second-
ary school, or higher education), marital status (married or 
cohabiting vs being single or widowed, or divorced), and 
financial status.
Then, each of the participants completed the set of ques-
tionnaires including: World Health Organization-Five Well- 
Being Index (WHO-5),22,23 Patient Health Questionnaire 
(PHQ-9),24,25 The Problem Areas in Diabetes (PAID)7,19 
and the diagnosis of depression was conducted with the use 
of Mini-International Neuropsychiatric Interview (M.I.N. 
I.).26,27
Measures
The measures used for the analyses presented in this study 
included:
1) The Polish version of The World Health 
Organization-Five Well-Being Index (WHO-5) 
questionnaire,22,23 which was used to assess general emo-
tional well-being. WHO-5 is a short, 5-item scale with 
satisfactory psychometric properties, in which participants 
rated how often they felt as described in the questionnaire 
in the previous 2 weeks using a 5-point Likert scale ran-
ging from 0 (not at all) to 5 (all the time).23 The scores 
were summed up, with higher scores indicating better 
emotional well-being. In our study sample, Cronbach α 
was 0.87.
2) The Patient Health Questionnaire (PHQ-9)24,25 
which was used to measure the severity of depressive 
symptoms. We employed the Polish version of PHQ-9.25 
This tool includes 9 items assessed on a 4-point Likert 
scale. Participants estimated the frequency of occurrence 
of certain states ranging from 0 (not at all) to 3 (nearly 
every day). The Polish version of PHQ-9 has very good 
psychometric properties.25 In our study sample, Cronbach 
α was 0.86.
3) The Problem Areas in Diabetes (PAID) scale,7,19 
which is a self-report questionnaire with 20 statements 
related to common negative emotions experienced by per-
sons with diabetes (eg, “Feeling alone with diabetes” and 
“Worrying about the future and the possibility of serious 
complications”). Respondents rate each item on a 6-point 
Likert scale ranging from 1 (“Not a problem”) to 6 
(“Serious problem”). The Joslin Diabetes Center, the 
owner of the PAID copyright, gave the senior author 
(AK) of this article the permission for the translation of 
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PAID into Polish. Two persons translated it into Polish, 
and then a fully bilingual person (a psychologist) trans-
lated them back into English. Items that differed were 
discussed in a group of psychologists including the trans-
lators. The Polish version of PAID was submitted to the 
Joslin Diabetes Center. The reliability of PAID scales, as 
indicated by Cronbach α, was 0.92 for the total PAID 
score, 0.90 for negative emotions, 0.46 for treatment- 
related problems, 0.57 for food-related problems, and 
0.61 for lack of social support.
4) The Mini-International Neuropsychiatric Interview 
(M.I.N.I.),26 Polish version 5.0.0.,27 which is a brief, 
widely used structured interview for the diagnosis of men-
tal disorders. The applied version was based on the 
Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) and International Classification 
of Diseases, Tenth Revision (ICD-10) criteria. There are 
no data on the psychometric properties of the Polish ver-
sion, but the psychometric properties of the original, 
English-language version of M.I.N.I. were assessed as 
very good on the basis of the Composite International 
Diagnostic Interview (CIDI). Regarding the diagnosis of 
depression, the sensitivity and specificity of M.I.N.I. were 
94% and 79%, respectively, and the kappa coefficient was 
0.83. The instrument can be used by clinicians after a short 
training. A more intensive training is required for 
nonprofessionals.
Statistical Analysis
Statistical analyses were carried out using the SPSS ver-
sion 25 for Windows. In order to identify the specific 
factors of the Polish version of PAID, exploratory factor 
analysis with an oblimin rotation was conducted, as we 
assumed that the factors were correlated. Due to non- 
normal data distribution, the principal axis factoring 
(PAF) method was applied. Cronbach α was calculated as 
a measure of internal consistency. To measure the concur-
rent and convergent validity, Pearson product-moment 
correlations were applied. We assumed that the PAID 
scores positively correlated with PHQ-9 results and nega-
tively with WHO-5 scores. We also investigated whether 
individuals with both diabetes and depression had higher 
PAID scores.
Results
The mean total PAID score was 11.00 (SD = 14.22; range 
0–62). The demographic, clinical, and psychologic char-
acteristics of both male and female outpatients with dia-
betes are presented in Table 1. There were no sex 
differences in the mean PHQ-9 and WHO-5 scores, age, 
HbA1c levels (%), or the duration of diabetes (years). 
A statistically significant difference in PAID scores 
between men and women was observed and is shown in 
Table 1. The women (M = 13.47, SD = 15.86) showed 
greater emotional distress than men (M = 9.21, SD = 
12.69), t(214) = 2.19; p = 0.03, Cohen d = 0.3.
The analysis established a one-factor structure of the 
Polish version of PAID with eigenvalues >1.0 (10.08; 
the second highest value was 0.59). The examination of 
the scree plot also suggested a one-factor structure (see 
Figure 1).
The factor loadings for the one-factor solution are 
presented in Table 2. However, this solution indicated 
that the factorial loadings of a single item (15. “Feeling 
unsatisfied with your diabetes physician”) did not place 
above the recommended value of 0.3.28 The total variance 
of the one-factor solution was 50.13%. The final Polish 
version of PAID has been made available free of charge 
Table 1 Demographic, Clinical, and Psychological Characteristics of Male and Female Outpatients with Diabetes
Variables Male (n =116) Female (n =100)
M SD M SD t-test p
Age (years) 57.54 7.17 58.37 7.46 t(214) = 0.899 0.370
HbA1c (percent) 6.92 1.20 6.89 1.23 t(194) = −1.72 0.864
Duration of diabetes (years) 10.30 7.38 8.51 6.62 t(214) = −1.87 0.064
PAID total score 9.21 12.69 13.47 15.86 t(214) = 2.19 0.029d
WHO-5 total score 16.50 6.36 15.36 6.61 t(214) = −1.29 0.198
Mean PHQ-9 total score 3.93 4.87 5.17 5.29 t(214) = 1.79 0.075
Note: dCohen’s d = 0.299 - small effect. 
Abbreviations: HBA1c, glycated hemoglobin; PAID, Problem Areas in Diabetes Questionnaire; PHQ-9, Patient Health Questionnaire; M, mean; SD, standard deviation; 
WHO-5, World Health Organization-Five Well-Being Index.
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(see Supplemental Material 1. Problem Areas in Diabetes 
Scale).
In the next step, we assessed the reliability of the PAID 
scale by calculating Cronbach α reliability coefficients. We 
obtained a Cronbach α of 0.95. Thus, the reliability of the 
Polish version of the PAID scale was very high, which 
indicated the homogeneous structure of the tool. To com-
pare our study version with the commonly used four-factor 
structure of PAID, we examined the reliability of the 
subdimensions by calculating Cronbach α reliability coef-
ficients. The results indicated that Cronbach α yielded 0.92 
for emotional problems, 0.43 for treatment-related pro-
blems, 0.74 for food-related problems, and 0.72 for social 
support–related problems. Thus, treatment-related pro-
blems demonstrated unsatisfactory reliability. Moreover, 
Cronbach α coefficients for food-related problems and 
Figure 1 Scree plot of the Polish version of the PAID.
Table 2 The Results of Principal Axis Factoring and Factor Loadings of the 20 PAID Items (N = 216) for One Factor Solution
Item Factor 1 Paid
6. Feeling depressed when you think about living with diabetes? 0.880
8. Feeling overwhelmed by your diabetes? 0.865
10. Feeling angry when you think about living with diabetes? 0.837
16. Feeling that diabetes is taking up too much of your mental and physical energy every day? 0.835
3. Feeling scared when you think about living with diabetes? 0.832
13. Feelings of guilt or anxiety when you get off track with your diabetes management? 0.812
20. Feeling “burned out” by the constant effort needed to manage diabetes? 0.802
14. Not “accepting” your diabetes? 0.794
2. Feeling discouraged with your diabetes treatment plan? 0.784
12. Worrying about the future and the possibility of serious complications? 0.761
17. Feeling alone with your diabetes? 0.754
19. Coping with complications of diabetes? 0.666
11. Feeling constantly concerned about food and eating? 0.660
4. Uncomfortable social situations related to your diabetes care (eg, people telling you what to eat)? 0.636
7. Not knowing if your mood or feelings are related to your diabetes 0.593
18. Feeling that your friends and family are not supportive of your diabetes management efforts? 0.576
5. Feelings of deprivation regarding food and meals? 0.541
9. Worrying about low blood sugar reactions? 0.467
1. Not having clear and concrete goals for your diabetes care? 0.452
15. Feeling unsatisfied with your diabetes physician? 0.199
Notes: Copyright © 1999–2021 by Joslin Diabetes Center. All rights reserved. Reprinted with permission. Adapted from Polonsky et al.7
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social support–related problems barely met the threshold 
of reliability.
Then, convergent validity was examined by calculating 
product-moment correlations between PAID scores and 
other measures of effect. As expected, there was 
a significant, moderate positive correlation between PAID 
and PHQ-9 (r = 0.556; p < 0.001). The analysis of the 
association of WHO-5 and PAID scales showed 
a moderate, significant negative correlation (r = −0.524; 
p < 0.001). Thus, higher scores of emotional distress were 
associated with poorer quality of life and more severe 
depressive symptoms. We used the Mini-International 
Neuropsychiatric Interview (M.I.N.I.) to control for the 
occurrence of current depression. This procedure allowed 
us to compare the results obtained with PAID in patients 
with depression and patients without depression. As we 
assumed, patients suffering from a depressive disorder 
obtained PAID results higher (M = 28.69; SD = 20.50; 
Mrank = 168.44) than patients without depressive symp-
toms (M = 8.14; SD = 10.41; Mrank = 98.08), U = 1026.00; 
p < 0.001, gHedges = 1.65. We observed a weak, significant 
negative correlation between PAID scores and age (r = 
−0.223; p = 0.001). This implies that younger individuals 
reported higher emotional distress. There was also a weak 
positive correlation between PAID scores and HbA1c 
levels (%) (r = 0.204; p = 0.004) (see Table 3). Thus, 
patients with the highest HbA1c levels experienced the 
most negative emotions.
Discussion
The factorial structure of the Polish version of PAID is 
similar to that of the original version of the instrument 
described by Welch et al.13 Namely, the results indicated 
that the structure of the Polish version of PAID may have 
a one-factor representation. This has also been found in the 
analysis of both the Brazilian18 and the Taiwanese ver-
sions of PAID,15 which yielded a single factor with high 
internal consistency.15,18 In both the Greek and the 
Swedish versions of PAID, the factor analysis identified 
a three-factor structure yet consisting of different subdi-
mensions. The two-factor solution was found for the 
Icelandic and Turkish versions of PAID. Our results sup-
port the conclusion from the review of the psychometric 
properties of PAID, which indicated that the internal struc-
ture of PAID varies across different populations. Our study 
confirmed the need for a proper assessment of psycho-
metric properties of scales and questionnaires translated 
from other languages. It also makes the published results 
of international studies that used the four-factor structure 
of PAID questionable, eg, those conducted in Croatia, 
Denmark, Germany, Ireland, Israel, the Netherlands, and 
Poland. Further research should aim to investigate the 
determinants of those cross-cultural differences. 
Moreover, instruments that have been translated or 
adapted across languages should be tested for equivalence 
in order to provide valuable information for interpreting 
results obtained in different cultures.29–31 This assumption 
relates to some types of equivalence, such as conceptual 
equivalence.31 With respect to PAID, this type of equiva-
lence refers to the ways in which problem areas in diabetes 
are conceptualized in various populations and in the values 
they assign to different domains of problems in diabetes. It 
seems that researchers automatically assume that domains 
that are relevant to problems among people with diabetes 
Table 3 The Results of the Correlation Analysis Between PAID Items and WHO-5, PHQ-9, Age, HbA1c and Duration of Diabetes (N = 216); 
Comparison of PAID Results in Individuals with and without Depression
Variables PAID Total
Statistic p
Age (years) r = −0.223 < 0.001
HbA1c (percent) r = 0.204 = 0.004
Duration of diabetes (years) r = 0.086 = 0.207
WHO-5 total score r = - 0.524 < 0.001
PHQ-9 total score r = 0.556 < 0.001
M (SD) Mrank Statistic p Effect size
Depression (n = 32) 28.69 (20.50) 168.44 U = 1026.00 < 0.001 gHedges = 1.65 large effect
No depression (n = 184) 8.14 (10.41) 98.08
Abbreviations: HBA1c, glycated hemoglobin; PAID, Problem Areas in Diabetes Questionnaire; PHQ-9, Patient Health Questionnaire; WHO-5, World Health 
Organization-Five Well-Being Index.
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in one population will also be relevant in other cultures. 
However, the adapted or translated instruments should be 
verified for problematic components or aspects in the tool 
that may be inadequate in certain populations.30 
Equivalence between different language versions of the 
same tool also refers to items.30 In addition, the relevance 
of PAID domains may vary across cultures, and the valid-
ity of the items as measures of particular problem areas 
may also differ, eg, the item “feel constantly concerned 
about eating” may not be applicable to cultures in which 
special food for diabetics is easily accessible. The item 
asking about feeling angry living with diabetes will not be 
appropriate in cultures in which the expression of anger is 
unacceptable. The failure to meet the assumption about 
equivalence may lead to test bias, which implies that 
inferences derived from test scores are not equivalent 
across various groups.32 The four-factor structure of 
PAID is widely used in research conducted among differ-
ent populations. Taking the above into account, using the 
one factor, short, five-item version of PAID seems not only 
beneficial in terms of saving the time but also appropriate 
for inferences derived from studies carried out among 
different populations.
This study investigated both the reliability and the 
validity of PAID in the Polish patients with diabetes. The 
Polish version of PAID has a very good internal consis-
tency and factorial validity.
In our study, its Cronbach α is 0.95. This result under-
lines the excellent internal consistency of the Polish ver-
sion of PAID. Notably, in the original study on PAID, the 
researchers observed a very similar Cronbach α (0.94)13 
and it has been also observed in other studies conducted in 
numerous populations.9–11,14–18 As mentioned before, the 
factorial structure of PAID is likely culture- 
specific.9–11,14–18 In our study, we investigated the relia-
bility of the components of the PAID scale by calculating 
Cronbach α reliability coefficients. We found that 
Cronbach α yielded 0.92 for emotional problems, 0.43 
for treatment-related problems, 0.74 for food-related pro-
blems, and 0.72 for social support–related problems. Some 
potential PAID factors demonstrated unsatisfactory con-
vergent validity.
Furthermore, we found support for the convergent and 
discriminative validity of the Polish version of PAID. The 
total scores of the PAID scale positively correlated with 
PHQ-9 scores and negatively with WHO-5 scores, which 
confirmed the validity of PAID as a useful tool to evaluate 
both the well-being and the severity of depressive 
symptoms in persons with diabetes. However, further 
research is needed to examine the Polish tool version for 
long-term stability and responsiveness to change.
Although the present study had a cross-sectional design 
and did not include interventional strategies, we controlled 
for the occurrence of current depression by using the Mini- 
International Neuropsychiatric Interview (MINI). Patients 
with diabetes and a depressive disorder obtained PAID 
results that were higher than those of patients with dia-
betes and no depressive symptoms.
We also conducted an additional analysis of the collected 
data, which exceeded the set study objectives. In line with 
previous studies,10 we found sex differences in the PAID 
measures, eg, women reported greater distress. In addition, 
younger individuals reported higher emotional distress. 
These findings support previous research results.18 It has 
been suggested that emotional distress in younger indivi-
duals may be higher because of a lower ability to cope with 
the management of a chronic disease, such as diabetes. The 
disability to cope with a serious chronic condition among 
younger patients should be considered in the treatment pro-
cess. It was shown that young people with diabetes had 
different health-care needs than older patients.33 Moreover, 
the most information and/or services related to type 2 dia-
betes are aimed at older adults.33 The low rate of participa-
tion in structured diabetes education sessions in the young 
population, caused by a short duration of diabetes in their 
life, may also lead to greater emotional distress. This sug-
gests that the duration of diabetes may be linked to the 
severity of distress. Indeed, some researchers have shown 
that shorter diabetes duration is related to higher levels of 
distress in patients with type 2 diabetes.34 However, we 
noted no significant correlation between the disease and 
the PAID scores in our study. Nevertheless, our replication 
of the relationship between younger age and emotional dis-
tress indicates that young patients should, ideally, be routi-
nely supported with psychologic interventions.
Conclusion
The Polish version of PAID is a one-factor, reliable, and 
valid measure for Polish patients with diabetes and it may 
be a useful tool for identifying those at increased risk of 
emotional distress.
Scales and questionnaires translated from other lan-
guages should be properly assessed with regard to their 
psychometric properties. Published results of international 
studies that used the four-factor structure of PAID are 
questionable without verification of its structure.
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